March 2024
1. TUNINETTI V, Virano E, Salutari V, Ricotti A, et al
   Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study.
   Eur J Cancer. 2024;203:114039.
   

   >> Share

   
   February 2024
2. TANAKA LF, Schoffer O, Schriefer D, Schauberger G, et al
   An audit of 1632 routinely collected cervical cancer screening smears from 398 women in Germany: Results from the TeQaZ Study.
   Eur J Cancer. 2024;201:113915.
   

   >> Share

   
   August 2023
3. DING S, Li H
   Re: A federated approach to identify women with early-stage cervical cancer at low risk of lymph node metastases.
   Eur J Cancer. 2023 Aug 1:112978. doi: 10.1016/j.ejca.2023.112978.
   

   >> Share

   
   February 2023
4. WENZEL HHB, Hardie AN, Moncada-Torres A, Hogdall CK, et al
   A federated approach to identify women with early-stage cervical cancer at low risk of lymph node metastases.
   Eur J Cancer. 2023;185:61-68.
   

   >> Share

   
   September 2022
5. KREGTING LM, Olthof EMG, Breekveldt ECH, Aitken CA, et al
   Concurrent participation in breast, cervical, and colorectal cancer screening in the Netherlands.
   Eur J Cancer. 2022;175:180-186.
   

   >> Share

   
   July 2022
6. OAKNIN A, Monk BJ, Vergote I, Cristina de Melo A, et al
   EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer.
   Eur J Cancer. 2022 Jul 31. pii: S0959-8049(22)00160.
   

   >> Share

   
   October 2021
7. CIBULA D, Dostalek L, Jarkovsky J, Mom CH, et al
   The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer.
   Eur J Cancer. 2021;158:111-122.
   

   >> Share

   
   May 2021
8. WENZEL HHB, Bekkers RLM, Lemmens VEPP, Van der Aa MA, et al
   No improvement in survival of older women with cervical cancer-A nationwide study.
   Eur J Cancer. 2021;151:159-167.
   

   >> Share

   
   March 2021
9. MATHEVET P, Lecuru F, Uzan C, Boutitie F, et al
   Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: Results of a multicentre randomised trial (SENTICOL-2).
   Eur J Cancer. 2021;148:307-315.
   

   >> Share

   
   
10. MATSUO K, Shimada M, Matsuzaki S, Enomoto T, et al
    Wait-time for adjuvant radiotherapy and oncologic outcome in early-stage cervical cancer: A treatment implication during the coronavirus pandemic.
    Eur J Cancer. 2021;148:117-120.
    

    >> Share

    
    December 2020
11. CIBULA D, Dostalek L, Hillemanns P, Scambia G, et al
    Completion of radical hysterectomy does not improve survival of patients with cervical cancer and intraoperatively detected lymph node involvement: ABRAX international retrospective cohort study.
    Eur J Cancer. 2020;143:88-100.
    

    >> Share

    
    September 2020
12. MATSUO K, Huang Y, Matsuzaki S, Klar M, et al
    Effect of delay in surgical therapy for early-stage cervical cancer: An implication in the coronavirus pandemic.
    Eur J Cancer. 2020;139:173-176.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share